Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia

American Journal of Otology

Volumn 21, Issue 1, 2000, Pages 24-27

  Ku, Peter K M ^a   Tong, Michael C F ^a   Lo, Phoebe ^a   Van Hasselt, Charles Andrew ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ear surgery; Local anesthesia; Nausea; Ondansetron; Vomiting

Indexed keywords

ONDANSETRON;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; PRIORITY JOURNAL;

EID: 0033987576     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0196-0709(00)80107-6     Document Type: Article

References (16)

1. Kenny G. Management of postoperative nausea and vomiting. Excerpta Medica 1993;1-4.
2. Cookson RF. Mechanisms and treatment of postoperative nausea and vomiting. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, eds. Nausea and Vomiting: Mechanisms and Treatment. Berlin: Springer-Verlag, 1986;130-50.
3. Reinhart DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesth Analg 1994;79:281-4.
4. Honkavaara P, Saarnivaara L, Klemola U-M. Prevention of nausea and vomiting with transdermal hyoscine in adults after middle ear surgery during general anaesthesia. Br J Anaesth 1994;73:763-6.
5. Yung MW. Local anaesthesia in middle ear surgery: survey of patients and surgeons. Clin Otolaryngol 1996;21:404-8.
6. Butler A, Hill JM, Ireland SJ, et al. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 reporters. Br J Pharmacol 1988;94:397-412.
7. Marty M, Pouillart P, Scholl S, et al. Comparison of the 5-hydroxytryptamine3 (serotinin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990;322:816-21.
8. Schmoll HJ. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Eur J Cancer Clin Oncol 1089;25(Suppl 1):S35-S33.
9. Prietman TJ. Clinical studies with ondansetron in the control of radiation-induced emesis. Eur J Cancer Clin Oncol 1989;25(Suppl 1):S29-S33.
10. McKenzie R, Kovac A, O'Connor T, et al. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Satellite Symposium: The Hague, 16 June 1992. Abstract Book: 53-56.
11. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 1996; 76:316-8.
12. van den Berg AA. A comparison of ondansetron and proclorperazine for the prevention of nausea and vomiting after tympanoplasty. Can J Anaesth 1996;43:939-45.
13. Palazzo MGA, Strunin L. Anaesthesia and emesis. Can Anaesth Soc J 1984;31:178-87
14. Pau HW, Hartwein J, Westhofen M. Air temperature in the outer ear canal - experimental studies in relation to radical cavity surgery. Laryngorhinootologie 1990;69:135-9.
15. Honkavaara P. Effect of transdermal hyocine on nausea and vomiting during and after middle ear surgery under local anaesthesia. Br J Anaesth 1996;76:49-53.
16. Anniko M, Hellstrom S, Schmidt SH, et al. Toxic effects on inner ear noxious agents passing through the round window membrane. Acta Otolaryngol Suppl (Stockh) 1989;457:49-56.